Author
Listed:
- Gustavo Fenalti
(Molecular Structure and Design, Bristol Myers Squibb)
- Nicolas Villanueva
(Molecular Structure and Design, Bristol Myers Squibb)
- Mark Griffith
(Protein Homeostasis, Bristol Myers Squibb)
- Barbra Pagarigan
(Molecular Structure and Design, Bristol Myers Squibb)
- Sirish Kaushik Lakkaraju
(Molecular Structure and Design, Bristol Myers Squibb)
- Richard Y.-C. Huang
(Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb)
- Nadia Ladygina
(Pharmacology, Bristol Myers Squibb)
- Alok Sharma
(Molecular Structure and Design, Bristol Myers Squibb)
- David Mikolon
(Discovery Biotherapeutics, Bristol Myers Squibb)
- Mahan Abbasian
(Discovery Biotherapeutics, Bristol Myers Squibb)
- Jeffrey Johnson
(Discovery Biotherapeutics, Bristol Myers Squibb)
- Haralambos Hadjivassiliou
(Discovery Biotherapeutics, Bristol Myers Squibb)
- Dan Zhu
(Discovery Biotherapeutics, Bristol Myers Squibb)
- Philip P. Chamberlain
(Protein Homeostasis, Bristol Myers Squibb)
- Ho Cho
(Discovery Biotherapeutics, Bristol Myers Squibb)
- Kandasamy Hariharan
(Discovery Biotherapeutics, Bristol Myers Squibb)
Abstract
CD47 is the only 5-transmembrane (5-TM) spanning receptor of the immune system. Its extracellular domain (ECD) is a cell surface marker of self that binds SIRPα and inhibits macrophage phagocytosis, and cancer immuno-therapy approaches in clinical trials are focused on blocking CD47/SIRPα interaction. We present the crystal structure of full length CD47 bound to the function-blocking antibody B6H12. CD47 ECD is tethered to the TM domain via a six-residue peptide linker (114RVVSWF119) that forms an extended loop (SWF loop), with the fundamental role of inserting the side chains of W118 and F119 into the core of CD47 extracellular loop region (ECLR). Using hydrogen-deuterium exchange and molecular dynamics simulations we show that CD47’s ECLR architecture, comprised of two extracellular loops and the SWF loop, creates a molecular environment stabilizing the ECD for presentation on the cell surface. These findings provide insights into CD47 immune recognition, signaling and therapeutic intervention.
Suggested Citation
Gustavo Fenalti & Nicolas Villanueva & Mark Griffith & Barbra Pagarigan & Sirish Kaushik Lakkaraju & Richard Y.-C. Huang & Nadia Ladygina & Alok Sharma & David Mikolon & Mahan Abbasian & Jeffrey Johns, 2021.
"Structure of the human marker of self 5-transmembrane receptor CD47,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25475-w
DOI: 10.1038/s41467-021-25475-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25475-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.